JPMorgan downgraded Crestwood Equity to Underweight from Neutral with a price target of $28, down from $30, following the company’s Q2 earnings results, which included EBITDA that was below the firm and the consensus estimates.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CEQP: